$2,730,000 of PFIZER INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)"
You can find more data on corporate lobbying on Quiver Quantitative.
PFE Congressional Stock Trading
Members of Congress have traded $PFE stock 9 times in the past 6 months. Of those trades, 4 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 05/30, 04/29 and 1 sale worth up to $15,000 on 08/05.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/16 and 1 sale worth up to $15,000 on 08/04.
- SENATOR RON WYDEN sold up to $15,000 on 06/03.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 06/03.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $50,000 on 05/15.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
PFE Hedge Fund Activity
We have seen 1,235 institutional investors add shares of PFE stock to their portfolio, and 1,486 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 26,490,160 shares (-25.6%) from their portfolio in Q2 2025, for an estimated $642,121,478
- BLACKROCK, INC. added 20,709,704 shares (+4.4%) to their portfolio in Q2 2025, for an estimated $502,003,224
- AMUNDI removed 14,642,887 shares (-28.1%) from their portfolio in Q2 2025, for an estimated $354,943,580
- MARSHALL WACE, LLP removed 13,641,127 shares (-96.8%) from their portfolio in Q2 2025, for an estimated $330,660,918
- CAPITAL WORLD INVESTORS removed 13,368,274 shares (-49.1%) from their portfolio in Q2 2025, for an estimated $324,046,961
- QUBE RESEARCH & TECHNOLOGIES LTD removed 10,711,578 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $259,648,650
- VICTORY CAPITAL MANAGEMENT INC added 10,400,851 shares (+220.6%) to their portfolio in Q2 2025, for an estimated $252,116,628
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PFE Price Targets
Multiple analysts have issued price targets for $PFE recently. We have seen 4 analysts offer price targets for $PFE in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $32.0 on 10/10/2025
- Tim Anderson from B of A Securities set a target price of $30.0 on 10/03/2025
- Andrew Baum from Citigroup set a target price of $26.0 on 08/06/2025
- Trung Huynh from UBS set a target price of $25.0 on 04/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
